Jean M. Delabar

Paris, 75013, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

EGCG-like non-competitive inhibitor of DYRK1A rescues cognitive defect in a down syndrome model.

EGCG-like non-competitive inhibitor of DYRK1A rescues cognitive defect in a down syndrome model.

Journal: European journal of medicinal chemistry

Published: October 06, 2023

Increased plasma DYRK1A with aging may protect against neurodegenerative diseases.

Increased plasma DYRK1A with aging may protect against neurodegenerative diseases.

Journal: Translational psychiatry

Published: December 12, 2022

Building the Future Therapies for Down Syndrome: The Third International Conference of the T21 Research Society.

Building the Future Therapies for Down Syndrome: The Third International Conference of the T21 Research Society.

Journal: Molecular syndromology

Published: October 05, 2020

Altered age-linked regulation of plasma DYRK1A in elderly cognitive complainers (INSIGHT-preAD study) with high brain amyloid load.

Altered age-linked regulation of plasma DYRK1A in elderly cognitive complainers (INSIGHT-preAD study) with high brain amyloid load.

Journal: Alzheimer's & dementia (New York, N. Y.)

Published: May 11, 2020

DYRK1A and cognition: A lifelong relationship.

DYRK1A and cognition: A lifelong relationship.

Journal: Pharmacology & therapeutics

Published: October 01, 2018

Paving the Way for Therapy: The Second International Conference of the Trisomy 21 Research Society.

Paving the Way for Therapy: The Second International Conference of the Trisomy 21 Research Society.

Journal: Molecular syndromology

Published: August 27, 2018

Prenatal treatment with EGCG enriched green tea extract rescues GAD67 related developmental and cognitive defects in Down syndrome mouse models.

Prenatal treatment with EGCG enriched green tea extract rescues GAD67 related developmental and cognitive defects in Down syndrome mouse models.

Journal: Scientific reports

Published: March 12, 2018

Rodent models in Down syndrome research: impact and future opportunities.

Rodent models in Down syndrome research: impact and future opportunities.

Journal: Disease models & mechanisms

Published: October 11, 2017

DYRK1A inhibition and cognitive rescue in a Down syndrome mouse model are induced by new fluoro-DANDY derivatives.

DYRK1A inhibition and cognitive rescue in a Down syndrome mouse model are induced by new fluoro-DANDY derivatives.

Journal: Scientific reports

Published: June 15, 2017

Combined assessment of DYRK1A, BDNF and homocysteine levels as diagnostic marker for Alzheimer's disease.

Combined assessment of DYRK1A, BDNF and homocysteine levels as diagnostic marker for Alzheimer's disease.

Journal: Translational psychiatry

Published: December 23, 2016

Overexpression of the DYRK1A Gene (Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A) Induces Alterations of the Serotoninergic and Dopaminergic Processing in Murine Brain Tissues.

Overexpression of the DYRK1A Gene (Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase 1A) Induces Alterations of the Serotoninergic and Dopaminergic Processing in Murine Brain Tissues.

Journal: Molecular neurobiology

Published: October 25, 2016

Specific age-related molecular alterations in the cerebellum of Down syndrome mouse models.

Specific age-related molecular alterations in the cerebellum of Down syndrome mouse models.

Journal: Brain research

Published: February 18, 2016

Showing 1-12 of 26

Last Updated: 09/26/2026